Adam Sussman focuses his practice on pharmaceutical and chemical patent preparation and prosecution. With years of experience challenging patent validity on behalf of generic pharmaceutical clients, he prosecutes patent applications to maximize enforcement potential.
Throughout his years of practice, Adam has drafted and prosecuted patent applications on various subject matters, including chemical compositions of matter, crystal forms, pharmaceutical formulations, dietary supplements, chemical processes, medical devices, probiotics, and orthodontic systems. He also has experience with additional diverse technical fields such as material science, organic chemistry and synthesis, and polymer science.
After earning a bachelor’s degree in chemistry with honors from the University of Pennsylvania, Adam moved to Chicago to pursue a doctoral degree and perform synthetic organic chemistry research at the University of Illinois. His research was featured in the Journal of the American Chemical Society in 2009, and he received a Ph.D. in chemistry from the University of Illinois at Chicago the following year. A skilled scientist as well as writer, Adam’s colleagues encouraged him to consider practicing patent law.
A Markey Scholar in Intellectual Property and a managing editor of The John Marshall Review of Intellectual Property Law, Adam graduated from The John Marshall Law School in 2014.
Recognition
- The John Marshall Law School: Markey Distinguished Scholar in Intellectual Property
Affiliations
Professional Activities and Memberships
- American Chemical Society, Small Chemical Business Development Subcommittee, Member
- Richard Linn American Inn of Court
Representative Matters
Representative Issued Patents
- 10,285,783 Pocket orthodontic bonding pad
- 10,280,190 Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions
- 10,271,926 Pocket orthodontic bonding pad
- 10,183,036 Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors
- 10,010,571 Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of use thereof
- 10,010,529 Extended release pharmaceutical formulations with controlled impurity levels
- 10,000,520 B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
- 9,975,915 Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof
Client Alerts & Newsletters
Firm News & Announcements